ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
•06 Nov 2023 01:11

Merger Arb Mondays (06 Nov) - Haitong Intl, NWS, Poly Culture, Eoflow, Origin, Azure, Tietto

This week, the highest gross spreads are 111 (57.1%), Eoflow (38.2%), Hollysys (21.4%), Origin Energy (12.7%), JSR (7.8%), Orecorp (9.9%), Lithium...

Logo
669 Views
Share
bullish•Origin Energy
•05 Nov 2023 07:05

Last Week in Event SPACE: Hokuhoku, Origin Energy, KDDI, BoJ

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
684 Views
Share
bullish•Eoflow
•05 Nov 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Tietto Teraoka Seisakusho, Symbio, Celltrion Health, EOFlow

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
720 Views
Share
bullish•Shriram Finance
•05 Nov 2023 05:30

Index Rebalance & ETF Flow Recap: NEXT50, SET50, L&F, Onewo, Celltrion, AMFI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
786 Views
Share
•02 Nov 2023 15:33

Celltrion Merger Update: Limits Lifted

Initially, the stock purchase rights limit was set at 1₩tn; however Celltrion Group's founder/Chairman Seo Jung-jin has removed this limit. That...

Logo
561 Views
Share
x